Literature DB >> 20360894

The prevalence of renal impairment in the elderly hospitalized population.

Maneshveri Pather1.   

Abstract

Renal impairment has already been cited as being under-reported. A retrospective cross-sectional study was carried out. The sample population consisted of 94 inpatients aged over 60 years at Clayponds Hospital in the UK who had been admitted for rehabilitation from acute hospitals. The glomerular filtration rate (GFR) was calculated using the Cockcroft-Gault formula modified for SI units. Renal impairment was found in 95.7% (95% CI: 91.8-99.6) of the sample (GFR < 90 ml/min). The study confirms that undetected renal impairment is prevalent. What is significant is that all of the subjects in this study were admitted from acute hospitals to Clayponds Hospital for rehabilitation. It is recommended that more attention be paid to the identification of patients with renal failure in hospitals owing to its significant morbidity and mortality.

Entities:  

Keywords:  GFR; elderly; renal impairment

Year:  2009        PMID: 20360894      PMCID: PMC2840563          DOI: 10.2147/ijgm.s5870

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


Introduction

Underdiagnosis of renal impairment has been reported.1 Diagnosis of renal impairment may be missed because of the inadequacy of screening. Progression to end-stage renal failure may be slowed when detected at an early stage.2 Chronic renal failure places a huge burden on health resources because dialysis or transplantation is necessary to prevent death.3 In addition, renal impairment is associated with increased cardiovascular risk.4 Complications may be minimized with effective detection and treatment. The estimated life-time risk and decrease in life expectancy associated with end-stage renal failure is comparable with that of colorectal cancer, breast cancer, and prostatic cancer.1 The purpose of this study was to establish the prevalence of undiagnosed renal impairment in the hospitalized elderly population.

Method

In order to assess the prevalence of undiagnosed renal impairment in the elderly hospitalized population, a retrospective cross-sectional study was carried out. The study population comprised 94 inpatients (n = 94) admitted to Clayponds Hospital for general rehabilitation between February and May 2005 from other acute hospitals. The patients comprised 69 women and 25 men all aged over 60 years. Medical and laboratory records for each subject were viewed, which included serum creatinine levels and the weight of each patient. The glomerular filtration rate (GFR; mL/min) for each patient was calculated using the modified Cockcroft–Gault formula:5 GFR in males can be obtained from the following equation, (140-age) * weight (kg)/814 * creatinine (mmol/l) and in females, 0.85 * (140-age) * weight (kg)/814 * creatinine (mmol/l). This was adjusted for International System of Units (SI) units. Patients admitted from acute hospitals to Clayponds Hospital for rehabilitation were included in the study irrespective of diagnosis. Patients admitted to Clayponds Hospital from home for the management of acute pathology were excluded owing to a greater likelihood of renal impairment being present in this population. A total of 119 patients were admitted to Clayponds Hospital between February 2005 and May 2005, however, 21 had to be excluded owing to the following factors: age under 60 years, a pre-existing diagnosis of renal failure, no weight documented during admission, no serum creatinine checked during admission stay, or admission from home for the management of acute pathologies. It was not the purpose of this study to examine confounding factors or co-morbidities.

Results

The degree of renal impairment was categorized based on the GFR as follows: no renal impairment, GFR ≥ 90 mL/min; mild impairment, GFR 60–89mL/min; moderate renal impairment, GFR 30–59 mL/min; and severe renal impairment, GFR 15–29 mL/min.6 As shown in Figure 1, 25 patients (26.6%, 95% confidence interval [CI]: 7.6–30.6) had mild renal impairment, 54 (57.4%, 95% CI: 47–67) had moderate renal impairment, 11 (11.7%, 95% CI: 5.2–18.2) had severe impairment, and only four (4.3%, 95% CI: 0.3–8) had normal renal function (Figure 1). The mean total GFR was 44.5 ± 20.9 mL/min.
Figure 1

Glomerularfiltrationrate(GFR) distribution

Discussion

This study has shown that renal impairment in the UK hospitalized elderly population is underdiagnosed. Most elderly patients entering UK hospitals for acute pathology have a serum creatinine and weight measurement taken during admission, but identification of renal impairment is mostly missed. The vast majority of subjects in this study (95.7%) had renal impairment as defined by GFR. More than 50% had a moderate impairment of renal function. This is significant as renal failure has major health implications as has already been stated. The study was limited by its small sample size and lack of randomization. However, it validates the fact that chronic renal disease is prevalent and underdiagnosed. It is recommended that hospitalized elderly patients with renal impairment be identified and managed appropriately. The implementation of this will require further work.
  8 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults.

Authors:  Olof Viktorsdottir; Runolfur Palsson; Margret B Andresdottir; Thor Aspelund; Vilmundur Gudnason; Olafur S Indridason
Journal:  Nephrol Dial Transplant       Date:  2005-05-31       Impact factor: 5.992

3.  Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program.

Authors:  Philip Kam-Tao Li; Bonnie Ching-Ha Kwan; Chi Bon Leung; Tze Hoi Kwan; Kim Ming Wong; Sing Leung Lui; Wai Kay Tsang; Christopher Chun Yu Mak; Siu Ka Mak; Alex Wai-Yin Yu; Sydney Tang
Journal:  Kidney Int Suppl       Date:  2005-04       Impact factor: 10.545

4.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

5.  Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.

Authors:  Daniel E Weiner; Hocine Tighiouart; Paul C Stark; Manish G Amin; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2004-08       Impact factor: 8.860

6.  Cardiovascular complications in renal failure.

Authors:  S G Rostand; J D Brunzell; R O Cannon; R G Victor
Journal:  J Am Soc Nephrol       Date:  1991-12       Impact factor: 10.121

7.  Prevalence of kidney damage in Australian adults: The AusDiab kidney study.

Authors:  Steven J Chadban; Esther M Briganti; Peter G Kerr; David W Dunstan; Timothy A Welborn; Paul Z Zimmet; Robert C Atkins
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

Review 8.  Screening for chronic kidney disease: unresolved issues.

Authors:  William M McClellan; Sylvia P B Ramirez; Claudine Jurkovitz
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

  8 in total
  3 in total

1.  Safety and efficacy of daptomycin as first-line treatment for complicated skin and soft tissue infections in elderly patients: an open-label, multicentre, randomized phase IIIb trial.

Authors:  Alexander Konychev; Markus Heep; Rose K C Moritz; Alexander Kreuter; Alexander Shulutko; Gerhard Fierlbeck; Kamel Bouylout; Rashidkhan Pathan; Uwe Trostmann; Ricardo L Chaves
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

Review 2.  Direct Oral Anticoagulants in Dental Patients Including the Frail Elderly Population.

Authors:  Hui Yin Lim; Prahlad Ho
Journal:  Dent J (Basel)       Date:  2016-03-19

3.  Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation.

Authors:  Jose María Mostaza; Carmen Suarez; Jose María Cepeda; Luis Manzano; Demetrio Sánchez
Journal:  BMC Cardiovasc Disord       Date:  2021-08-09       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.